Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826533) titled 'Intravenous Papaverine for Term Prelabor Rupture of Membranes' on Sept. 7.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Care Provider).

Primary Sponsor: Wolfson Medical Center

Condition: Premature Rupture of Fetal Membranes

Intervention: Drug: Papaverine

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: March 20, 2025

Target Sample Size: 200

Countries of Recruitment: Israel

To know more, visit https://clinicaltrials.gov/study/NCT07826533

Published by HT Digital Con...